Publications

Publications Euro-MOTOR Consortium

1    Family history of neurodegenerative and vascular diseases in ALS    M.H.B. Huisman    Neurology    77    Lippincott Williams and Wilkins    21-9-2011    1363-1369    10.1212/WNL.0b013e318231530b
2    An ALS case with a novel D90N-SOD1 heterozygous missense mutation    Andrea Calvo     Amyotrophic Lateral Sclerosis    Vol. 13/Issue 4    Informa Healthcare    UK    1-6-2012    393-395    10.319/17482968.2012.673170
3    Systemic Down-Regulation of Delta-9 Desaturase Promotes Muscle Oxidative Metabolism and Accelerates Muscle Function Recovery following Nerve Injury    Ghulam Hussain    PLoS One    8    Public Library of Science    13-6-2013    1-sep    10.1371/journal.pone.0064525
4    DeepSAGE reveals genetic variants associated with alternative polyadenylation and expression of coding and non-coding transcripts.    Zhernakova DV    PLoS Genetics    9    Public Library of Science    20-6-2013    1003594    10.1371/journal.pgen.1003594
5    ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN    Ewout Groen    Human Molecular Genetics    22    Oxford University Press    15-5-2013    3690-3704    10.1093/hmg/ddt222
6    Are professional soccer players at higher risk for ALS?    Ettore Beghi    Amyotrophic Lateral Sclerosis    1    Informa Healthcare    25-5-2013    1-jun    10.3109/21678421.2013.809764
7    The dynactin p150 subunit: cell biology studies of sequence changes found in ALS/MND and Parkinsonian Syndromes    Marianne Stockmann    Journal of Neural Transmission    120    Springer Verlag    11-11-2011    785-798    10.1007/s00702-012-0910-z
8    Aggregation of neurologic and neuropsychiatric disease in ALS kindreds: A population based case controlled cohort study of Familial and Sporadic ALS.    Byrne S    Annals of Neurology    Epub ahead of print    John Wiley and Sons Inc.    9-7-2013    1    10.1002/ana.23969
9    Credibility Analysis of Putative Disease-Causing Genes Using Bioinformatics    Olubunmi Abel    PLoS One    8    Public Library of Science    5-6-2013    64899    10.1371/journal.pone.0064899
10    Homozygosity analysis in amyotrophic lateral sclerosis    Kin Mok    European Journal of Human Genetics    2013    Nature Publishing Group    24-4-2013    1-jul    10.1038/ejhg.2013.59
11    Residual association at C9orf72 suggests an alternative amyotrophic lateral sclerosis-causing hexanucleotide repeat    Ashley R. Jones    Neurobiology of Aging    34    Elsevier Inc.         12-4-2013    2234    10.1016/j.neurobiolaging.2013.03.003
12    H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis    Wouter van Rheenen    Neurobiology of Aging    5    Elsevier Inc.         11-10-2012    1517    10.1016/j.neurobiolaging.2012.07.020
13    Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis    Lorna Taylor    Journal of Neurology, Neurosurgery and Psychiatry    84    BMJ Publishing Group    2-10-2012    494-498    10.1136/jnnp-2012-303851
14    Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1    The ALSGEN Consortium    Neurobiology of Aging    34    Elsevier Inc.         29-7-2012    357    10.1016/j.neurobiolaging.2012.07.017
15    Proteome-Wide Analysis of Disease-Associated SNPs That Show Allele-Specific Transcription Factor Binding    Falk Butter    PLoS Genetics    8    Public Library of Science    27-9-2012    1002982    10.1371/journal.pgen.1002982
16    Local axonal function of STAT3 rescues axon degeneration in the pmn model of motoneuron disease    Bhuvaneish Selvaraj    Journal of Cell Biology    199    Rockefeller University Press    29-10-2012    437-451    10.1083/jcb.201203109
17    Simultaneous and independent detection of C9ORF72 alleles with low and high number of GGGGCC repeats using an optimised protocol of Southern blot hybridisation.    Buchman VL    Molecular Neurodegeneration    8    BioMed Central    8-1-2012    8-dec    10.1186/1750-1326-8-12
18    C9ORF72 expansions, parkinsonism, and Parkinson disease: A clinicopathologic study    Cooper-Knock J    Neurology    81    Lippincott Williams and Wilkins    24-7-2013    808-811    10.1212/WNL.0b013e3182a2cc38
19    Mutant Copper-Zinc Superoxide Dismutase (SOD1) Induces Protein Secretion Pathway Alterations and Exosome Release in Astrocytes    Manuela Basso    Journal of Biological Chemistry    288    American Society for Biochemistry and Molecular Biology Inc.    16-4-2013    15699-15711    10.1074/jbc.M112.425066
20    Degeneration of serotonergic neurons in amyotrophic lateral sclerosis: a link to spasticity    Dentel C    Brain; a journal of neurology    136    Oxford University Press    31-10-2012    483-493    10.1093/brain/aws274
21    Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosis    Kabashi E    Human Molecular Genetics    22    Oxford University Press    26-2-2013    2350-2360    10.1093/hmg/ddt080
22    Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with age.    Eschbach J    Neurobiology of Disease    58    Academic Press Inc.    4-6-2013    220-230    10.1016/j.nbd.2013.05.015
23    The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol.    Kalmar B    Pharmacology and Therapeutics    ?    Elsevier Inc.         23-8-2013    ?    10.1016/j.pharmthera.2013.08.003
24    Treatment with a coinducer of the heat shock response delays muscle denervation in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.    Kalmar B    Amyotrophic Lateral Sclerosis    13    Informa Healthcare    16-5-2012    378-92    10.3109/17482968.2012.660953
25    Plasma neurofilament heavy chain levels correlate to markers of late stage disease progression and treatment response in SOD1(G93A) mice that model ALS.    Lu CH    PLoS One    7    Public Library of Science    16-7-2012    40998    10.1371/journal.pone.0040998
26    Hydroximic acid derivatives: pleiotropic hsp co-inducers restoring homeostasis and robustness.    Crul T    Current Pharmaceutical Design    19    Bentham Science Publishers B.V.    10-6-2013    309-46    10.2174/1381612811306030309
27    FUS is not dysregulated by the spinal bulbar muscular atrophy androgen receptor polyglutamine repeat expansion.    Fratta P    Neurobiology of Aging    34    Elsevier Inc.         9-10-2012    17-19    10.1016/j.neurobiolaging.2012.09.008
28    Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion.    Mitchell JC    Acta Neuropathologica    125    Springer Verlag    9-9-2012    273-88    10.1007/s00401-012-1043-z
29    Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy.    Malik B    Brain; a journal of neurology    136    Oxford University Press    7-2-2012    926-43    10.1093/brain/aws343
30    Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature    Chiò A.     Neuroepidemiology    41    S. Karger AG    11-7-2013    118-130    10.1159/000351153
31    Genetic counselling in ALS: facts, uncertainties and clinical suggestions    Adriano Chiò    Journal of Neurology, Neurosurgery and Psychiatry    ?    BMJ Publishing Group    26-9-2013    1-aug    10.1136/jnnp-2013-305546
32    The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson's disease and other degenerative parkinsonisms    Antonino Cannas    Neurogenetics    14    Springer Verlag    2-4-2013    161-166    10.1007/s10048-013-0360-2
33    Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis    Franco Franchignoni    Journal of Neurology, Neurosurgery and Psychiatry    ?    BMJ Publishing Group    20-3-2013    1-jun    10.1136/jnnp-2012-304701
34    Pathogenic VCP Mutations Induce Mitochondrial Uncoupling and Reduced ATP Levels    Fernando Bartolome    Neuron    78    Cell Press         10-4-2013    57-64    10.1016/j.neuron.2013.02.028
35    Controversies and priorities in amyotrophic lateral sclerosis    Turner MR    Lancet Neurology, The    12    Lancet Publishing Group    1-3-2013    310-22    10.1016/S1474-4422(13)70036-X
36    Extensive genetics of ALS: a population-based study in Italy.    Chiò A    Neurology    79    Lippincott Williams and Wilkins    6-11-2012    1983-1989    10.1212/WNL.0b013e3182735d36
37    Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995–2009    Maura Pugliatti    Journal of Neurology    260    D. Steinkopff-Verlag    30-9-2012    572-579    10.1007/s00415-012-6681-5
38    UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study    Adriano Chiòa    Neurobiology of Aging    34    Elsevier Inc.         25-7-2012    357.e1-357.e5    10.1016/j.neurobiolaging.2012.07.016
39    Amyotrophic lateral sclerosis/frontotemporal dementia with predominant manifestations of obsessive–compulsive disorder associated to GGGGCC expansion of the c9orf72 gene    Andrea Calvo    Journal of Neurology    259    D. Steinkopff-Verlag    24-8-2012    2723-2725    10.1007/s00415-012-6640-1
40    Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality    Bede P.    Journal of Neurology, Neurosurgery and Psychiatry    84    BMJ Publishing Group    20-10-2012    766-773    
41    Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing    Kenna    Journal of Medical Genetics    50    BMJ Publishing Group    23-7-2013    776-783    10.1136/jmedgenet-2013-101795
42    Using Reference Databases of Genetic Variation to Evaluate the Potential Pathogenicity of Candidate Disease Variants    Kevin P. Kenna     Human Mutation    Vol. 34/Issue 6    Wiley-Liss Inc.    US    1-6-2013    836-841    10.1002/humu.22303
43    Survival analysis of irish amyotrophic lateral sclerosis patients diagnosed from 1995-2010    Rooney J.    PLoS One    8-sep    Public Library of Science    30-9-2013    e74733    10.1371/journal.pone.0074733
44    UBQLN2 mutations are not a frequent cause of amyotrophic lateral sclerosis in Ireland    Russell Lewis McLaughlin     Neurobiology of Aging    Vol. 35/Issue 1    Elsevier Inc.    United States    1-1-2014    267.e9-267.e11    10.1016/j.neurobiolaging.2013.07.023
45    The epidemiology of ALS: a conspiracy of genes, environment and time    Ammar Al-Chalabi     Nature Reviews Neurology    Vol. 9/Issue 11    Nature Publishing Group    United Kingdom    15-10-2013    617-628    10.1038/nrneurol.2013.203
46    SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis    E. Rubino     Neurology    Vol. 79/Issue 15    Lippincott Williams and Wilkins    United States    9-10-2012    1556-1562    10.1212/WNL.0b013e31826e25df
47    No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis    A. Goris     Human Molecular Genetics    1    Oxford University Press    United Kingdom    11-11-2013    1-jul    10.1093/hmg/ddt574
48    A de novo nonsense mutation of the FUS gene in an apparently familial amyotrophic lateral sclerosis case    Andrea Calvo     Neurobiology of Aging    1    Elsevier Inc.    United States    1-12-2013    1-mei    10.1016/j.neurobiolaging.2013.12.028
49    The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients    Angelina Cistaro     European Journal of Nuclear Medicine and Molecular Imaging    1    Springer Verlag    Germany    21-1-2014    1-jul    10.1007/s00259-013-2667-5
50    State of play in amyotrophic lateral sclerosis genetics    Alan E Renton     Nature Neuroscience    Vol. 17/Issue 1    Nature Publishing Group    United Kingdom    26-12-2013    17-23    10.1038/nn.3584
51    A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis    I. Fogh et all    Human Molecular Genetics    1    Oxford University Press    United Kingdom    21-1-2014    1-dec    10.1093/hmg/ddt587
52    Systematic identification of trans eQTLs as putative drivers of known disease associations    Harm-Jan Westra et al.    Nature Genetics    Vol. 45/Issue 10    Nature Publishing Group    United Kingdom    8-9-2013    1238-1243    10.1038/ng.2756
53    Trauma and amyotrophic lateral sclerosis: a case-control study from a population-based registry    E. Pupillo     European Journal of Neurology    Vol. 19/Issue 12    Blackwell Publishing    United Kingdom    1-12-2012    1509-1517    10.1111/j.1468-1331.2012.03723.x
54    Mapping of Gene Expression Reveals CYP27A1 as a Susceptibility Gene for Sporadic ALS    F.P.Diekstra    PLoS One    Vol. 7/Issue 4    Public Library of Science    United States    11-4-2012    e35333    10.1371/journal.pone.0035333
55    EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans    Annelies Van Hoecke     Nature Medicine    Vol. 18/Issue 9    Nature Publishing Group    United Kingdom    26-8-2012    1418-1422    10.1038/nm.2901
56    The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder    Smith    European Journal of Human Genetics    Vol. 21/Issue 1    Nature Publishing Group    United Kingdom    1-1-2013    102-108    10.1038/ejhg.2012.98
57    UNC13A is a modifier of survival in amyotrophic lateral sclerosis    Frank P. Diekstra     Neurobiology of Aging    Vol. 33/Issue 3    Elsevier Inc.    United States    1-3-2012    630.e3-630.e8    10.1016/j.neurobiolaging.2011.10.029
58    Frequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort study    Sarah Debray     Neurobiology of Aging    Vol. 34/Issue 12    Elsevier Inc.    United States    1-12-2013    2890.e7-2890.e12    10.1016/j.neurobiolaging.2013.06.009
59    Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis    T. Philips     Brain; a journal of neurology    Vol. 136/Issue 2    Oxford University Press    United Kingdom    1-2-2013    471-482    10.1093/brain/aws339
60    Clinical implications of recent breakthroughs in amyotrophic lateral sclerosis    Philip Van Damme     Current Opinion in Neurology    Vol. 26/Issue 5    Lippincott Williams and Wilkins    United States    1-1-2013    466-472    10.1097/WCO.0b013e328364c063
61    Genetic ablation of phospholipase C delta 1 increases survival in SOD1G93A mice    Kim A. Staats     Neurobiology of Disease    Vol. 60    Academic Press Inc.    United States    1-12-2013    nov-17    10.1016/j.nbd.2013.08.006
62    Rapamycin increases survival in ALS mice lacking mature lymphocytes    Kim A Staats     Molecular Neurodegeneration    Vol. 8/Issue 1    BioMed Central    United Kingdom    1-1-2013    31    10.1186/1750-1326-8-31
63    Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS    I. Taes     Human Molecular Genetics    Vol. 22/Issue 9    Oxford University Press    United Kingdom    1-5-2013    1783-1790    10.1093/hmg/ddt028
64    Molecular Signatures of Amyotrophic Lateral Sclerosis Disease Progression in Hind and Forelimb Muscles of an SOD1    Daniele Capitanio     Antioxidants and Redox Signaling    Vol. 17/Issue 10    Mary Ann Liebert Inc.    United States    15-11-2012    1333-1350    10.1089/ars.2012.4524
65    Amyotrophic Lateral Sclerosis Multiprotein Biomarkers in Peripheral Blood Mononuclear Cells    Giovanni Nardo     PLoS One    Vol. 6/Issue 10    Public Library of Science    United States    5-10-2011    e25545    10.1371/journal.pone.0025545
66    Hypoxia causes autophagic stress and derangement of metabolic adaptation in a cell model of amyotrophic lateral sclerosis    Sara Cimini     Journal of Neurochemistry    J Neurochem.    Blackwell Publishing    United Kingdom    1-1-2014    n/a-n/a    10.1111/jnc.12642
67    Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis    G. Nardo     Brain; a journal of neurology    Vol. 136/Issue 11    Oxford University Press    United Kingdom    1-11-2013    3305-3332    10.1093/brain/awt250
68    Amyloid precursor protein (APP) contributes to pathology in the SOD1G93A mouse model of amyotrophic lateral sclerosis    J. B. Bryson     Human Molecular Genetics    Vol. 21/Issue 17    Oxford University Press    United Kingdom    1-9-2012    3871-3882    10.1093/hmg/dds215
69    Molecular Chaperone Mediated Late-Stage Neuroprotection in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis    Sergey S. Novoselov     PLoS One    Vol. 8/Issue 8    Public Library of Science    United States    30-8-2013    e73944    10.1371/journal.pone.0073944
70    Cytoplasmic dynein heavy chain: the servant of many masters    Giampietro Schiavo     Trends in Neurosciences    Vol. 36/Issue 11    Elsevier Limited    United Kingdom    1-11-2013    641-651    10.1016/j.tins.2013.08.001
71    A Nonsense Mutation in Mouse Tardbp Affects TDP43 Alternative Splicing Activity and Causes Limb-Clasping and Body Tone Defects    Thomas Ricketts     PLoS One    Vol. 9/Issue 1    Public Library of Science    United States    21-1-2014    e85962    10.1371/journal.pone.0085962
72    Trans-eQTLs Reveal That Independent Genetic Variants Associated with a Complex Phenotype Converge on Intermediate Genes, with a Major Role for the HLA    Fehrmann     PLoS Genetics    Vol. 7/Issue 8    Public Library of Science    United States    4-8-2011    e1002197    10.1371/journal.pgen.1002197
73    Unraveling the Regulatory Mechanisms Underlying Tissue-Dependent Genetic Variation of Gene Expression    Jingyuan Fu     PLoS Genetics    Vol. 8/Issue 1    Public Library of Science    United States    19-1-2012    e1002431    10.1371/journal.pgen.1002431
74    Genetics of familial amyotrophic lateral sclerosis    P. N. Valdmanis     Neurology    Vol. 70/Issue 2    Lippincott Williams and Wilkins    United States    5-12-2007    144-152    10.1212/01.wnl.0000296811.19811.db
75    Gene expression profiling in human neurodegenerative disease    Johnathan Cooper-Knock     Nature Reviews Neurology    Vol. 8/Issue 9    Nature Publishing Group    United Kingdom    14-8-2012    518-530    10.1038/nrneurol.2012.156
76    C9ORF72 transcription in a frontotemporal dementia case with two expanded alleles    J. Cooper-Knock     Neurology    Vol. 81/Issue 19    Lippincott Williams and Wilkins    United States    5-11-2013    1719-1721    10.1212/01.wnl.0000435295.41974.2e
77    Comparison of Blood RNA Extraction Methods Used for Gene Expression Profiling in Amyotrophic Lateral Sclerosis    Nadhim Bayatti     PLoS One    Vol. 9/Issue 1    Public Library of Science    United States    27-1-2014    e87508    10.1371/journal.pone.0087508
78    The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype    Johnathan Cooper-Knock     Acta Neuropathologica    Vol. 127/Issue 3    Springer Verlag    Germany    1-3-2014    333-345    10.1007/s00401-014-1251-9
79    Neuronal dark matter: the emerging role of microRNAs in neurodegeneration    Emily F. Goodall     Frontiers in Cellular Neuroscience    Vol. 7    Frontiers Research Foundation    Switzerland    1-1-2013    0    10.3389/fncel.2013.00178
80    Investigating cell death mechanisms in amyotrophic lateral sclerosis using transcriptomics    Paul R. Heath     Frontiers in Cellular Neuroscience    Vol. 7    Frontiers Research Foundation    Switzerland    1-1-2013    0    10.3389/fncel.2013.00259
81    Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72    A. Ismail     Journal of Neurology, Neurosurgery and Psychiatry    Vol. 84/Issue 1    BMJ Publishing Group    United Kingdom    1-1-2013    79-87    10.1136/jnnp-2012-303326
82    Lack of unique neuropathology in amyotrophic lateral sclerosis associated with p.K54E angiogenin (    J. Kirby     Neuropathology and Applied Neurobiology    Vol. 39/Issue 5    Blackwell Publishing    United Kingdom    1-8-2013    562-571    10.1111/nan.12007
83    HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1–induced Charcot-Marie-Tooth disease    Constantin d'Ydewalle     Nature Medicine    Vol. 17/Issue 8    Nature Publishing Group    United Kingdom    24-7-2011    968-974    10.1038/nm.2396
84    Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology    M. H. B. Huisman     Journal of Neurology, Neurosurgery and Psychiatry    Vol. 82/Issue 10    BMJ Publishing Group    United Kingdom    1-10-2011    1165-1170    10.1136/jnnp.2011.244939
85    Evidence for an oligogenic basis of amyotrophic lateral sclerosis    M. van Blitterswijk     Human Molecular Genetics    Vol. 21/Issue 17    Oxford University Press    United Kingdom    1-9-2012    3776-3784    10.1093/hmg/dds199
86    VCP mutations in familial and sporadic amyotrophic lateral sclerosis    Max Koppers     Neurobiology of Aging    Vol. 33/Issue 4    Elsevier Inc.    United States    1-4-2012    837.e7-837.e13    10.1016/j.neurobiolaging.2011.10.006
87    Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2    P. Van Damme     Neurology    Vol. 76/Issue 24    Lippincott Williams and Wilkins    United States    14-6-2011    2066-2072    10.1212/WNL.0b013e31821f445b
88    No evidence for a large difference in ALS frequency in populations of African and European origin: A population based study in inner city London    Ricardo Rojas-Garcia     Amyotrophic Lateral Sclerosis    Vol. 13/Issue 1    Informa Healthcare    United Kingdom    1-1-2012    66-68    10.3109/17482968.2011.636049
89    The risk to relatives of patients with sporadic amyotrophic lateral sclerosis    M. F. Hanby     Brain; a journal of neurology    Vol. 134/Issue 12    Oxford University Press    United Kingdom    1-12-2011    3454-3457    10.1093/brain/awr248
90    The chromosome 9 ALS and FTD locus is probably derived from a single founder    Mok     Neurobiology of Aging    Vol. 33/Issue 1    Elsevier Inc.    United States    1-1-2012    209.e3-209.e8    10.1016/j.neurobiolaging.2011.08.005
91    Loss of nuclear TDP-43 in ALS causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurons    J Robin Highley     Neuropathology and Applied Neurobiology    0    Blackwell Publishing    United Kingdom    1-4-2014    n/a-n/a    10.1111/nan.12148
92    Gene expression signatures in motor neuron disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions    Rohini Raman     Neuropathology and Applied Neurobiology    0    Blackwell Publishing    United Kingdom    1-4-2014    n/a-n/a    10.1111/nan.12147
93    Modelling the Effects of Penetrance and Family Size on Rates of Sporadic and Familial Disease    Ammar Al-Chalabi     Human Heredity    Vol. 71/Issue 4    S. Karger AG    Switzerland    1-1-2011    281-288    10.1159/000330167
94    Keeping up with genetic discoveries in amyotrophic lateral sclerosis: The ALSoD and ALSGene databases    Christina M. Lill     Amyotrophic Lateral Sclerosis    Vol. 12/Issue 4    Informa Healthcare    United Kingdom    1-7-2011    238-249    10.3109/17482968.2011.584629
95    Clinical diagnosis and management of amyotrophic lateral sclerosis    Orla Hardiman     Nature Reviews Neurology    Vol. 7/Issue 11    Nature Publishing Group    United Kingdom    11-10-2011    639-649    10.1038/nrneurol.2011.153
96    Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis    Laura Ferraiuolo     Nature Reviews Neurology    Vol. 7/Issue 11    Nature Publishing Group    United Kingdom    1-11-2011    616-630    10.1038/nrneurol.2011.152
97    ALS clinical trials: Do enrolled patients accurately represent the ALS population?    A. Chio     Neurology    Vol. 77/Issue 15    Lippincott Williams and Wilkins    United States    11-10-2011    1432-1437    10.1212/WNL.0b013e318232ab9b
98    A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD    Renton     Neuron    Vol. 72/Issue 2    Cell Press    United States    1-10-2011    257-268    10.1016/j.neuron.2011.09.010
99    Muscle Gene Expression Is a Marker of Amyotrophic Lateral Sclerosis Severity    Pierre-François Pradat     Neurodegenerative Diseases    Vol. 9/Issue 1    S. Karger AG    Switzerland    1-1-2012    38-52    10.1159/000329723
100    Can Transcriptomics Cut the Gordian Knot of Amyotrophic Lateral Sclerosis?    Alexandre Henriques     Current Genomics    Vol. 12/Issue 7    Bentham Science Publishers B.V.    Netherlands    1-11-2011    506-515    10.2174/138920211797904043
101    Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: Implication for protein aggregation and immune response    Caterina Bendotti     Progress in Neurobiology    Vol. 97/Issue 2    Elsevier Limited    United Kingdom    1-5-2012    101-126    10.1016/j.pneurobio.2011.10.001
102    Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: A prospective study    Maarten Schrooten     Annals of Neurology    Vol. 70/Issue 1    John Wiley and Sons Inc.    United States    1-7-2011    79-83    10.1002/ana.22380
103    Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease    Thomas Philips     Lancet Neurology, The    Vol. 10/Issue 3    Lancet Publishing Group    United Kingdom    1-3-2011    253-263    10.1016/S1474-4422(11)70015-1
104    ELP3 Controls Active Zone Morphology by Acetylating the ELKS Family Member Bruchpilot    Katarzyna Miśkiewicz     Neuron    Vol. 72/Issue 5    Cell Press    United States    1-12-2011    776-788    10.1016/j.neuron.2011.10.010
105    CGG-repeat expansion in FMR1 is not associated with amyotrophic lateral sclerosis    Ewout J.N. Groen     Neurobiology of Aging    Vol. 33/Issue 8    Elsevier Inc.    United States    1-8-2012    1852.e1-1852.e3    10.1016/j.neurobiolaging.2012.03.007
106    NIPA1 polyalanine repeat expansions are associated with amyotrophic lateral sclerosis    H. M. Blauw     Human Molecular Genetics    Vol. 21/Issue 11    Oxford University Press    United Kingdom    1-6-2012    2497-2502    10.1093/hmg/dds064
107    Rare and common paraoxonase gene variants in amyotrophic lateral sclerosis patients    Marka van Blitterswijk     Neurobiology of Aging    Vol. 33/Issue 8    Elsevier Inc.    United States    1-8-2012    1845.e1-1845.e3    10.1016/j.neurobiolaging.2012.01.007
108    On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia    F. Geser     Progress in Neurobiology    Vol. 95/Issue 4    Elsevier Limited    United Kingdom    1-12-2011    649-662    10.1016/j.pneurobio.2011.08.011
109    A Distinct MR Imaging Phenotype in Amyotrophic Lateral Sclerosis: Correlation between T1 Magnetization Transfer Contrast Hyperintensity along the Corticospinal Tract and Diffusion Tensor Imaging Analysis    G. Carrara     American Journal of Neuroradiology    Vol. 33/Issue 4    American Society of Neuroradiology    United States    1-4-2012    733-739    10.3174/ajnr.A2855
110    A proposed staging system for amyotrophic lateral sclerosis    J. C. Roche     Brain; a journal of neurology    Vol. 135/Issue 3    Oxford University Press    United Kingdom    1-3-2012    847-852    10.1093/brain/awr351
111    MixupMapper: correcting sample mix-ups in genome-wide datasets increases power to detect small genetic effects    H.-J. Westra     Bioinformatics    Vol. 27/Issue 15    Oxford University Press    United Kingdom    1-8-2011    2104-2111    10.1093/bioinformatics/btr323
112    UBQLN2 in familial amyotrophic lateral sclerosis in the Netherlands    Perry T.C. van Doormaal     Neurobiology of Aging    Vol. 33/Issue 9    Elsevier Inc.    United States    1-9-2012    2233.e7-2233.e8    10.1016/j.neurobiolaging.2012.02.032
113    Whole-genome sequencing reveals a coding non-pathogenic variant tagging a non-coding pathogenic hexanucleotide repeat expansion in C9orf72 as cause of amyotrophic lateral sclerosis    S. Herdewyn     Human Molecular Genetics    Vol. 21/Issue 11    Oxford University Press    United Kingdom    1-6-2012    2412-2419    10.1093/hmg/dds055
114    Infection of the Central Nervous System, Sepsis and Amyotrophic Lateral Sclerosis    Fang Fang     PLoS One    Vol. 6/Issue 12    Public Library of Science    United States    27-12-2011    e29749    10.1371/journal.pone.0029749
115    Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72    J. Cooper-Knock     Brain; a journal of neurology    Vol. 135/Issue 3    Oxford University Press    United Kingdom    1-3-2012    751-764    10.1093/brain/awr365
116    Tubulin-binding cofactor B is a direct interaction partner of the dynactin subunit p150Glued    Georges F. Kuh     Cell and Tissue Research    Vol. 350/Issue 1    Springer Verlag    Germany    1-10-2012    13-26    10.1007/s00441-012-1463-z
117    Charcot-Marie-Tooth disease: Emerging mechanisms and therapies    Constantin d’Ydewalle     International Journal of Biochemistry and Cell Biology    Vol. 44/Issue 8    Elsevier Limited    United Kingdom    1-8-2012    1299-1304    10.1016/j.biocel.2012.04.020
118    HDAC6 at the Intersection of Neuroprotection and Neurodegeneration    Constantin d'Ydewalle     Traffic    Vol. 13/Issue 6    Blackwell Munksgaard    Denmark    1-6-2012    771-779    10.1111/j.1600-0854.2012.01347.x
119    Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study    Elisa Majounie     Lancet Neurology, The    Vol. 11/Issue 4    Lancet Publishing Group    United Kingdom    1-4-2012    323-330    10.1016/S1474-4422(12)70043-1
120    C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population    Mario Sabatelli     Neurobiology of Aging    Vol. 33/Issue 8    Elsevier Inc.    United States    1-8-2012    1848.e15-1848.e20    10.1016/j.neurobiolaging.2012.02.011
121    Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset    Angelina Cistaro     European Journal of Nuclear Medicine and Molecular Imaging    Vol. 39/Issue 2    Springer Verlag    Germany    1-2-2012    251-259    10.1007/s00259-011-1979-6
122    ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations    A. Chio     Journal of Neurology, Neurosurgery and Psychiatry    Vol. 83/Issue 7    BMJ Publishing Group    United Kingdom    1-7-2012    730-733    10.1136/jnnp-2012-302219
123    Neurobehavioral dysfunction in ALS has a negative effect on outcome and use of PEG and NIV    A. Chio     Neurology    Vol. 78/Issue 14    Lippincott Williams and Wilkins    United States    3-4-2012    1085-1089    10.1212/WNL.0b013e31824e8f53
124    Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72    A. Chio     Brain; a journal of neurology    Vol. 135/Issue 3    Oxford University Press    United Kingdom    1-3-2012    784-793    10.1093/brain/awr366
125    Pain in amyotrophic lateral sclerosis: a population-based controlled study    A. Chiò     European Journal of Neurology    Vol. 19/Issue 4    Blackwell Publishing    United Kingdom    1-4-2012    551-555    10.1111/j.1468-1331.2011.03540.x
126    Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases    W. van Rheenen     Neurology    Vol. 79/Issue 9    Lippincott Williams and Wilkins    United States    28-8-2012    878-882    10.1212/WNL.0b013e3182661d14
127    VAPB and C9orf72 mutations in 1 familial amyotrophic lateral sclerosis patient    Marka van Blitterswijk     Neurobiology of Aging    Vol. 33/Issue 12    Elsevier Inc.    United States    1-12-2012    2950.e1-2950.e4    10.1016/j.neurobiolaging.2012.07.004
128    The genetics and neuropathology of amyotrophic lateral sclerosis    Ammar Al-Chalabi     Acta Neuropathologica    Vol. 124/Issue 3    Springer Verlag    Germany    1-9-2012    339-352    10.1007/s00401-012-1022-4
129    Mutation analysis of VCP in British familial and sporadic amyotrophic lateral sclerosis patients    Jack W. Miller     Neurobiology of Aging    Vol. 33/Issue 11    Elsevier Inc.    United States    1-11-2012    2721.e1-2721.e2    10.1016/j.neurobiolaging.2012.06.003
130    ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics    Olubunmi Abel     Human Mutation    Vol. 33/Issue 9    Wiley-Liss Inc.    United States    1-9-2012    1345-1351    10.1002/humu.22157
131    Common Genetic Variants and Gene-Expression Changes Associated with Bipolar Disorder Are Over-Represented in Brain Signaling Pathway Genes    Inti Pedroso     Biological Psychiatry    Vol. 72/Issue 4    Elsevier USA    United States    1-8-2012    311-317    10.1016/j.biopsych.2011.12.031
132    Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study    Susan Byrne     Lancet Neurology, The    Vol. 11/Issue 3    Lancet Publishing Group    United Kingdom    1-3-2012    232-240    10.1016/S1474-4422(12)70014-5
133    Identifying potential risk factors for developing amyotrophic lateral sclerosis    Adriano Chiò     Neurodegenerative Diseases    Vol. 1/Issue 6    S. Karger AG    1-12-2011    463-471    10.2217/nmt.11.64
134    Non-invasive ventilation in amyotrophic lateral sclerosis: a 10 year population based study    A. Chio     Journal of Neurology, Neurosurgery and Psychiatry    Vol. 83/Issue 4    BMJ Publishing Group    United Kingdom    1-4-2012    377-381    10.1136/jnnp-2011-300472
135    The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study    J. Phukan     Journal of Neurology, Neurosurgery and Psychiatry    Vol. 83/Issue 1    BMJ Publishing Group    United Kingdom    1-1-2012    102-108    10.1136/jnnp-2011-300188
136    Screening for OPTN mutations in a cohort of British amyotrophic lateral sclerosis patients    Lauren Johnson     Neurobiology of Aging    Vol. 33/Issue 12    Elsevier Inc.    United States    1-12-2012    2948.e15-2948.e17    10.1016/j.neurobiolaging.2012.06.023
137    Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study    Ammar Al-Chalabi     Lancet Neurology, The    Vol. 13/Issue 11    Lancet Publishing Group    United Kingdom    1-11-2014    1108-1113    10.1016/S1474-4422(14)70219-4
138    The evaluation of pain in amyotrophic lateral sclerosis: A case controlled observational study    Victoria C. J. Wallace     Health Care and Informatics Review Online    0    Enigma Publishing Ltd.    23-9-2014    1-aug    10.3109/21678421.2014.951944
139    Motor neuron disease: Common genetic variants and the heritability of ALS    Ammar Al-Chalabi     Nature Reviews Neurology    Vol. 10/Issue 10    Nature Publishing Group    United Kingdom    9-9-2014    549-550    10.1038/nrneurol.2014.166
140    C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-widemeta-analysis    FP Diekstra     Annals of Neurology    Vol. 76/Issue 1    John Wiley and Sons Inc.    United States    1-7-2014    120-133    10.1002/ana.24198
141    Evidence of an environmental effect on survival in ALS    Noa Keren     Healthcare Papers    0    Longwoods Publishing Corp.    23-9-2014    1-jun    10.3109/21678421.2014.911326
142    Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale    Rubika Balendra     Healthcare Papers    Vol. 15/Issue 3-4    Longwoods Publishing Corp.    1-6-2014    279-284    10.3109/21678421.2014.897357
143    Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis    Ashley R. Jones     Healthcare Papers    Vol. 15/Issue 3-4    Longwoods Publishing Corp.    1-6-2014    285-291    10.3109/21678421.2013.872149
144    An Evaluation of a SVA Retrotransposon in the FUS Promoter as a Transcriptional Regulator and Its Association to ALS    Abigail L. Savage     PLoS One    Vol. 9/Issue 3    Public Library of Science    United States    7-3-2014    e90833    10.1371/journal.pone.0090833
145    Psychological as well as illness factors influence acceptance of non-invasive ventilation (NIV) and gastrostomy in amyotrophic lateral sclerosis (ALS): A prospective population study    Naomi H. Martin     Healthcare Papers    Vol. 15/Issue 5-6    Longwoods Publishing Corp.    1-9-2014    376-387    10.3109/21678421.2014.886700
146    Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials    R. Balendra     Journal of Neurology, Neurosurgery and Psychiatry    0    BMJ Publishing Group    United Kingdom    24-1-2014    1    10.1136/jnnp-2013-306865
147    Exome-wide Rare Variant Analysis Identifies TUBA4A Mutations Associated with Familial ALS    BN. Smith     Neuron    Vol. 84/Issue 2    Cell Press    United States    1-10-2014    324-331    10.1016/j.neuron.2014.09.027
148    Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study    PT.C. van Doormaal     Neurobiology of Aging    Vol. 35/Issue 10    Elsevier Inc.    United States    1-10-2014    2420.e13-2420.e14    10.1016/j.neurobiolaging.2014.04.014
149    C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration    Stephanie May     Acta Neuropathologica    Vol. 128/Issue 4    Springer Verlag    Germany    1-10-2014    485-503    10.1007/s00401-014-1329-4
150    Deep proteomic evaluation of primary and cell line motoneuron disease models delineates major differences in neuronal characteristics    D. Hornburg     Molecular and Cellular Proteomics    111    American Society for Biochemistry and Molecular Biology Inc.    United States    5-9-2014    111    10.1074/mcp.M113.037291
151    Intermediate length C9orf72 expansion in an ALS patient without classical C9orf72 neuropathology    Alexander M. Beer     Amyotrophic Lateral Sclerosis    0    Informa Healthcare    1-12-2014    1-mrt    10.3109/21678421.2014.977296
152    Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions    J. Cooper-Knock     Brain; a journal of neurology    Vol. 137/Issue 7    Oxford University Press    United Kingdom    1-7-2014    2040-2051    10.1093/brain/awu120
153    TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions    Michael D. Gallagher     Acta Neuropathologica    Vol. 127/Issue 3    Springer Verlag    Germany    1-3-2014    407-418    10.1007/s00401-013-1239-x
154    Prior medical conditions and the risk of amyotrophic lateral sclerosis    Meinie Seelen     Journal of Neurology    Vol. 261/Issue 10    D. Steinkopff-Verlag    Germany    1-10-2014    1949-1956    10.1007/s00415-014-7445-1
155    Residential exposure to extremely low frequency electromagnetic fields and the risk of ALS    M. Seelen     Neurology    Vol. 83/Issue 19    Lippincott Williams and Wilkins    United States    4-11-2014    1767-1769    10.1212/WNL.0000000000000952
156    A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories    C. Akimoto     Journal of Medical Genetics    Vol. 51/Issue 6    BMJ Publishing Group    United Kingdom    1-6-2014    419-424    10.1136/jmedgenet-2014-102360
157    Amyotrophic Lateral Sclerosis Outcome Measures and the Role of Albumin and Creatinine    Adriano Chiò     JAMA Neurology    Vol. 71/Issue 9    American Medical Association    United States    1-9-2014    1134    10.1001/jamaneurol.2014.1129
158    Heritability of Amyotrophic Lateral Sclerosis    Isabella Fogh     JAMA Neurology    Vol. 71/Issue 12    American Medical Association    United States    1-12-2014    1579    10.1001/jamaneurol.2014.3493
159    Physical activity and amyotrophic lateral sclerosis: A European population-based case-control study    Elisabetta Pupillo     Annals of Neurology    Vol. 75/Issue 5    John Wiley and Sons Inc.    United States    1-5-2014    708-716    10.1002/ana.24150
160    NADPH oxidase (NOX2) activity is a modifier of survival in ALS    Giuseppe Marrali     Journal of Neurology    Vol. 261/Issue 11    D. Steinkopff-Verlag    Germany    1-11-2014    2178-2183    10.1007/s00415-014-7470-0
161    Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm    Marwa Elamin     Journal of Neurology    Vol. 262/Issue 6    D. Steinkopff-Verlag    Germany    1-6-2015    1447-1454    10.1007/s00415-015-7731-6
162    From genome to function by studying eQTLs    Harm-Jan Westra     Biochimica et Biophysica Acta - Molecular Basis of Disease    Vol. 1842/Issue 10    Elsevier    Netherlands    1-10-2014    1896-1902    10.1016/j.bbadis.2014.04.024
163    Social deprivation and population density are not associated with small area risk of amyotrophic lateral sclerosis    James P.K. Rooney     Environmental Research    Vol. 142    Academic Press Inc.    United States    1-10-2015    141-147    10.1016/j.envres.2015.06.024
164    No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy    Meinie Seelen     Neurobiology of Aging    Vol. 35/Issue 8    Elsevier Inc.    United States    1-8-2014    1956.e9-1956.e11    10.1016/j.neurobiolaging.2014.01.152
165    Genetic architecture of ALS in Sardinia    Giuseppe Borghero     Neurobiology of Aging    Vol. 35/Issue 12    Elsevier Inc.    United States    1-12-2014    2882.e7-2882.e12    10.1016/j.neurobiolaging.2014.07.012
166    Novel mutations support a role for Profilin 1 in the pathogenesis of ALS    Bradley N. Smith     Neurobiology of Aging    Vol. 36/Issue 3    Elsevier Inc.    United States    1-3-2015    1602.e17-1602.e27    10.1016/j.neurobiolaging.2014.10.032
167    Stratified gene expression analysis identifies major amyotrophic lateral sclerosis genes    Ashley R. Jones     Neurobiology of Aging    Vol. 36/Issue 5    Elsevier Inc.    United States    1-5-2015    2006.e1-2006.e9    10.1016/j.neurobiolaging.2015.02.017
168    ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry    Giuseppe Borghero     Neurobiology of Aging    Vol. 36/Issue 10    Elsevier Inc.    United States    1-10-2015    2906.e1-2906.e5    10.1016/j.neurobiolaging.2015.06.013
169    HFE p.H63D polymorphism does not influence ALS phenotype and survival    Adriano Chiò     Neurobiology of Aging    Vol. 36/Issue 10    Elsevier Inc.    United States    1-10-2015    2906.e7-2906.e11    10.1016/j.neurobiolaging.2015.06.016
170    Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes    Adriano Chiò     Lancet Neurology, The    Vol. 13/Issue 12    Lancet Publishing Group    United Kingdom    1-12-2014    1228-1240    10.1016/S1474-4422(14)70167-X
171    Biological interpretation of genome-wide association studies using predicted gene functions    Tune H. Pers     Nature Communications    Vol. 6    Nature Publishing Group    United Kingdom    19-1-2015    5890    10.1038/ncomms6890
172    Gene expression analysis identifies global gene dosage sensitivity in cancer    Rudolf S N Fehrmann     Nature Genetics    Vol. 47/Issue 2    Nature Publishing Group    United Kingdom    12-1-2015    115-125    10.1038/ng.3173
173    Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis    Janel O Johnson     Nature Neuroscience    Vol. 17/Issue 5    Nature Publishing Group    United Kingdom    30-3-2014    664-666    10.1038/nn.3688
174    Motor neuron disease in 2014: Biomarkers for ALS—in search of the Promised Land    Adriano Chiò     Nature Reviews Neurology    Vol. 11/Issue 2    Nature Publishing Group    United Kingdom    23-12-2014    72-74    10.1038/nrneurol.2014.250
175    Mutations in the CHCHD10 gene are a common cause of familial amyotrophic lateral sclerosis    J. O. Johnson     Brain; a journal of neurology    Vol. 137/Issue 12    Oxford University Press    United Kingdom    1-12-2014    e311-e311    10.1093/brain/awu265
176    Are CHCHD10 mutations indeed associated with familial amyotrophic lateral sclerosis?    W. van Rheenen     Brain; a journal of neurology    Vol. 137/Issue 12    Oxford University Press    United Kingdom    1-12-2014    e313-e313    10.1093/brain/awu299
177    Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways    E. T. Cirulli     Science    Vol. 347/Issue 6229    American Association for the Advancement of Science    United States    27-3-2015    1436-1441    10.1126/science.aaa3650
178    Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy    A. Montuschi     Journal of Neurology, Neurosurgery and Psychiatry    Vol. 86/Issue 2    BMJ Publishing Group    United Kingdom    1-2-2015    168-173    10.1136/jnnp-2013-307223
179    A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland    James Rooney     Journal of Neurology, Neurosurgery and Psychiatry    Vol. 86/Issue 5    BMJ Publishing Group    United Kingdom    1-5-2015    496-501    10.1136/jnnp-2014-309601
180    Calling genotypes from public RNA-sequencing data enables identification of genetic variants that affect gene-expression levels    Patrick Deelen     Genome Medicine    Vol. 7/Issue 1    BioMed Central    United Kingdom    1-12-2015    jan-13    10.1186/s13073-015-0152-4
181    Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis    M. Pagani     Neurology    Vol. 83/Issue 12    Lippincott Williams and Wilkins    United States    16-9-2014    1067-1074    10.1212/WNL.0000000000000792
182    ATXN2 polyQ intermediate repeats are a modifier of ALS survival    A. Chio     Neurology    Vol. 84/Issue 3    Lippincott Williams and Wilkins    United States    20-1-2015    251-258    10.1212/WNL.0000000000001159
183    Spatial cluster analysis of population amyotrophic lateral sclerosis risk in Ireland    J. Rooney     Neurology    Vol. 84/Issue 15    Lippincott Williams and Wilkins    United States    14-4-2015    1537-1544    10.1212/WNL.0000000000001477
184    ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons    J. Lenzi     DMM Disease Models and Mechanisms    Vol. 8/Issue 7    Company of Biologists Ltd    United Kingdom    1-7-2015    755-766    10.1242/dmm.020099
185    Cell Specific eQTL Analysis without Sorting Cells    Harm-Jan Westra     PLoS Genetics    Vol. 11/Issue 5    Public Library of Science    United States    8-5-2015    e1005223    10.1371/journal.pgen.1005223
186    An Exploratory Spatial Analysis of ALS Incidence in Ireland over 17.5 Years (1995 – July 2013)    James Rooney     PLoS One    Vol. 9/Issue 5    Public Library of Science    United States    27-5-2014    e96556    10.1371/journal.pone.0096556
187    Invited Review: Decoding the pathophysiological mechanisms that underlie RNA dysregulation in neurodegenerative disorders: a review of the current state of the art    Matthew J. Walsh     Neuropathology and Applied Neurobiology    Vol. 41/Issue 2    Blackwell Publishing    United Kingdom    1-2-2015    109-134    10.1111/nan.12187
188    A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis    L. Palamiuc     EMBO Molecular Medicine    Vol. 7/Issue 5    Wiley-Blackwell    United States    1-5-2015    526-546    10.15252/emmm.201404433
189    A plural role for lipids in motor neuron diseases: energy, signaling and structure    Florent Schmitt     Frontiers in Cellular Neuroscience    Vol. 8    Frontiers Research Foundation    Switzerland    1-1-2014    jan-13    10.3389/fncel.2014.00025
190    Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated with TDP-43 proteinopathy    Johnathan Cooper-Knock     Acta Neuropathologica    Vol. 130/Issue 1    Springer Verlag    Germany    1-7-2015    63-75    10.1007/s00401-015-1429-9
191    Blood Cell Palmitoleate-Palmitate Ratio Is an Independent Prognostic Factor for Amyotrophic Lateral Sclerosis    Alexandre Henriques     PLoS One    Vol. 10/Issue 7    Public Library of Science    United States    6-7-2015    e0131512    10.1371/journal.pone.0131512
192    C9ORF72 GGGGCC Expanded Repeats Produce Splicing Dysregulation which Correlates with Disease Severity in Amyotrophic Lateral Sclerosis    Johnathan Cooper-Knock     PLoS One    Vol. 10/Issue 5    Public Library of Science    United States    27-5-2015    e0127376    10.1371/journal.pone.0127376
193    C-kit is important for SOD1G93A mouse survival independent of mast cells    K.A. Staats     Neuroscience    Vol. 301    Elsevier Limited    United Kingdom    1-8-2015    415-420    10.1016/j.neuroscience.2015.06.026
194    Comment: The environmental and genetic impact of spatial cluster analysis in ALS    J. H. Veldink    Neurology    Vol. 84/Issue 15    Lippincott Williams and Wilkins    United States    14-4-2015    1543-1543    10.1212/WNL.0000000000001481
195    Comparative Magnetic Resonance Imaging and Histopathological Correlates in Two SOD1 Transgenic Mouse Models of Amyotrophic Lateral Sclerosis    Ilaria Caron     PLoS One    Vol. 10/Issue 7    Public Library of Science    United States    1-7-2015    e0132159    10.1371/journal.pone.0132159
196    Developments in treatments for amyotrophic lateral sclerosis via intracerebroventricular or intrathecal delivery    Philip Van Damme     Expert Opinion on Investigational Drugs    Vol. 23/Issue 7    Informa Healthcare    United Kingdom    1-7-2014    955-963    10.1517/13543784.2014.912275
197    Differences in protein quality control correlate with phenotype variability in 2 mouse models of familial amyotrophic lateral sclerosis    Marianna Marino     Neurobiology of Aging    Vol. 36/Issue 1    Elsevier Inc.    United States    1-1-2015    492-504    10.1016/j.neurobiolaging.2014.06.026
198    Gene expression changes in spinal motoneurons of the SOD1G93A transgenic model for ALS after treatment with G-CSF    Alexandre Henriques     Frontiers in Cellular Neuroscience    Vol. 8    Frontiers Research Foundation    Switzerland    20-1-2015    jan-13    10.3389/fncel.2014.00464
199    Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS    Ana Jovičić     Nature Neuroscience    Vol. 18/Issue 9    Nature Publishing Group    United Kingdom    26-8-2015    1226-1229    10.1038/nn.4085
200    NKCC1 downregulation induces hyperpolarizing shift of GABA responsiveness at near term fetal stages in rat cultured dorsal root ganglion neurons    Joelle N Chabwine     BMC Neuroscience    Vol. 16/Issue 1    BioMed Central    United Kingdom    1-12-2015    jan-13    10.1186/s12868-015-0180-4
201    Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice    Sarah Herdewyn     Molecular Neurodegeneration    Vol. 9/Issue 1    BioMed Central    United Kingdom    1-1-2014    24    10.1186/1750-1326-9-24
202    The Spectrum of C9orf72-mediated Neurodegeneration and Amyotrophic Lateral Sclerosis    Johnathan Cooper-Knock     Neurotherapeutics    Vol. 12/Issue 2    Springer New York    United States    1-4-2015    326-339    10.1007/s13311-015-0342-1
203    Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS)    Lindsay Poppe     Experimental Neurology    Vol. 262    Academic Press Inc.    United States    1-12-2014    138-151    10.1016/j.expneurol.2014.07.001
204    Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase    Alexandre Henriques     Human Molecular Genetics    Vol. 24/Issue 25    Oxford University Press    United Kingdom    20-12-2015    7390-7405    10.1093/hmg/ddv439
205    Smoking, Alcohol Consumption, and the Risk of Amyotrophic Lateral Sclerosis: A Population-based Study    S. W. de Jong     American Journal of Epidemiology    Vol. 176/Issue 3    Oxford University Press    United Kingdom    1-8-2012    233-239    10.1093/aje/kws015
206    Amyotrophic lateral sclerosis is not linked to multiple sclerosis in a population based study    P. T. C. van Doormaal     Journal of Neurology, Neurosurgery and Psychiatry    Vol. 84/Issue 8    BMJ Publishing Group    United Kingdom    1-8-2013    940-941    10.1136/jnnp-2012-304864
207    Bicyclic-Capped Histone Deacetylase 6 Inhibitors with Improved Activity in a Model of Axonal Charcot–Marie–Tooth Disease    Sida Shen     ACS Chemical Neuroscience    Vol. 7/Issue 2    American Chemical Society    United States    17-2-2016    240-258    10.1021/acschemneuro.5b00286
208    Blood Biomarkers for Amyotrophic Lateral Sclerosis: Myth or Reality?    Laura Robelin     BioMed Research International    Vol. 2014    Hindawi Publishing Corporation    United States    1-1-2014    1-nov    10.1155/2014/525097
209    Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis    Adriano Chiò     Journal of Neurology, Neurosurgery and Psychiatry    Vol. 86/Issue 1    BMJ Publishing Group    United Kingdom    1-1-2015    38-44    10.1136/jnnp-2013-306589
210    Developmental and Functional Nature of Human iPSC Derived Motoneurons    Marianne Stockmann     Stem Cell Reviews and Reports    Vol. 9/Issue 4    Humana Press    United States    1-8-2013    475-492    10.1007/s12015-011-9329-4
211    Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy    Christian M. Simon     Acta Neuropathologica    Vol. 130/Issue 3    Springer Verlag    Germany    1-9-2015    373-387    10.1007/s00401-015-1446-8
212    Effect of Presymptomatic Body Mass Index and Consumption of Fat and Alcohol on Amyotrophic Lateral Sclerosis    Mark H. B. Huisman     JAMA Neurology    Vol. 72/Issue 10    American Medical Association    United States    1-10-2015    1155    10.1001/jamaneurol.2015.1584
213    Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients    Gaëlle Bruneteau     Annals of Clinical and Translational Neurology    Vol. 2/Issue 4    Wiley    United States    1-4-2015    362-372    10.1002/acn3.179
214    Lifetime physical activity and the risk of amyotrophic lateral sclerosis    M. H. B. Huisman     Journal of Neurology, Neurosurgery and Psychiatry    Vol. 84/Issue 9    BMJ Publishing Group    United Kingdom    1-9-2013    976-981    10.1136/jnnp-2012-304724
215    Long-term survival in amyotrophic lateral sclerosis: A population-based study    Elisabetta Pupillo     Annals of Neurology    Vol. 75/Issue 2    John Wiley and Sons Inc.    United States    1-2-2014    287-297    10.1002/ana.24096
216    Mechanisms for axon maintenance and plasticity in motoneurons: alterations in motoneuron disease    Sibylle Jablonka     Journal of Anatomy    Vol. 224/Issue 1    Blackwell Publishing    United Kingdom    1-1-2014    mrt-14    10.1111/joa.12097
217    Moving towards treatments for spinal muscular atrophy: hopes and limits    Brunhilde Wirth     Expert Opinion on Emerging Drugs    Vol. 20/Issue 3    Informa Healthcare    United Kingdom    3-7-2015    353-356    10.1517/14728214.2015.1041375
218    No association between soil constituents and amyotrophic lateral sclerosis relative risk in Ireland    James Rooney     Environmental Research    Vol. 147    Academic Press Inc.    United States    1-5-2016    102-107    10.1016/j.envres.2016.01.038
219    Progranulin is Neurotrophic In Vivo and Protects against a Mutant TDP-43 Induced Axonopathy    Angela S. Laird     PLoS One    Vol. 5/Issue 10    Public Library of Science    United States    13-10-2010    e13368    10.1371/journal.pone.0013368
220    Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis    Hajer El Oussini     Acta Neuropathologica    Vol. 131/Issue 3    Springer Verlag    Germany    1-3-2016    465-480    10.1007/s00401-016-1534-4
221    SMN1 gene duplications are associated with sporadic ALS    H. M. Blauw     Neurology    Vol. 78/Issue 11    Lippincott Williams and Wilkins    United States    13-3-2012    776-780    10.1212/WNL.0b013e318249f697
222    Subcellular transcriptome alterations in a cell culture model of spinal muscular atrophy point to widespread defects in axonal growth and presynaptic differentiation    Lena Saal     RNA    Vol. 20/Issue 11    Cold Spring Harbor Laboratory Press    United States    1-11-2014    1789-1802    10.1261/rna.047373.114
223    Synthesis and SAR assessment of novel Tubathian analogs in the pursuit of potent and selective HDAC6 inhibitors    Rob De Vreese     Organic and Biomolecular Chemistry    Vol. 14/Issue 8    Royal Society of Chemistry    United Kingdom    1-1-2016    2537-2549    10.1039/c5ob02625c
224    Whole transcriptome profiling reveals the RNA content of motor axons    Michael Briese     Nucleic Acids Research    Vol. 44/Issue 4    Oxford University Press    United Kingdom    29-2-2016    e33-e33    10.1093/nar/gkv1027
225    The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis    Jean-Philippe Loeffler     Brain Pathology    43101    Blackwell Publishing    United Kingdom    1-1-2016    n/a-n/a    10.1111/bpa.12350
226    Oligogenic inheritance of optineurin ( OPTN ) and C9ORF72 mutations in ALS highlights localisation of OPTN in the TDP-43-negative inclusions of C9ORF72 -ALS    Joanna J. Bury     Neuropathology    45505    Blackwell Publishing    United Kingdom    1-1-2015    n/a-n/a    10.1111/neup.12240
227    Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate-length CAG repeat expansions in Ataxin-2 does not have 1C2-positive polyglutamine inclusions    John Robin Highley     Neuropathology and Applied Neurobiology    1    Blackwell Publishing    United Kingdom    1-8-2015    n/a-n/a    10.1111/nan.12254
228    Lysosomal and phagocytic activity is increased in astrocytes during disease progression in the SOD1 G93A mouse model of amyotrophic lateral sclerosis    David J. Baker     Frontiers in Cellular Neuroscience    Vol. 9    Frontiers Research Foundation    Switzerland    15-10-2015    1    10.3389/fncel.2015.00410
229    Deletion or Inhibition of the Oxygen Sensor PHD1 Protects against Ischemic Stroke via Reprogramming of Neuronal Metabolism    Annelies Quaegebeur     Cell Metabolism    Vol. 23/Issue 2    Cell Press    United States    1-2-2016    280-291    10.1016/j.cmet.2015.12.007
230    Fatting the brain: a brief of recent research    Ghulam Hussain     Frontiers in Cellular Neuroscience    Vol. 7    Frontiers Research Foundation    Switzerland    1-1-2013    144    10.3389/fncel.2013.00144
231    Beta-2 microglobulin is important for disease progression in a murine model for amyotrophic lateral sclerosis    Kim A. Staats     Frontiers in Cellular Neuroscience    Vol. 7    Frontiers Research Foundation    Switzerland    1-1-2013    7-249    10.3389/fncel.2013.00249
232    ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion    Adriano Chiò     Neurobiology of Aging    Vol. 39    Elsevier Inc.    United States    1-3-2016    218.e5-218.e8    10.1016/j.neurobiolaging.2015.11.027
233    Amyotrophic lateral sclerosis is not linked to multiple sclerosis in a population based study    P. T. C. van Doormaal     Journal of Neurology, Neurosurgery and Psychiatry    Vol. 84/Issue 8    BMJ Publishing Group    United Kingdom    1-8-2013    940-941    10.1136/jnnp-2012-304864
234    Deletion or Inhibition of the Oxygen Sensor PHD1 Protects against Ischemic Stroke via Reprogramming of Neuronal Metabolism    Annelies Quaegebeur     Cell Metabolism    Vol. 23/Issue 2    Cell Press    United States    1-2-2016    280-291    10.1016/j.cmet.2015.12.007
235    A Nonsense Mutation in Mouse Tardbp Affects TDP43 Alternative Splicing Activity and Causes Limb-Clasping and Body Tone Defects    Thomas Ricketts     PLoS One    Vol. 9/Issue 1    Public Library of Science    United States    21-1-2014    e85962    10.1371/journal.pone.0085962
236    Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate-length CAG repeat expansions in Ataxin-2 does not have 1C2-positive polyglutamine inclusions    John Robin Highley     Neuropathology and Applied Neurobiology    1    Blackwell Publishing    United Kingdom    1-8-2015    n/a-n/a    10.1111/nan.12254
237    Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients    Gaëlle Bruneteau     Annals of Clinical and Translational Neurology    Vol. 2/Issue 4    Wiley    United States    1-4-2015    362-372    10.1002/acn3.179
238    Amyotrophic lateral sclerosis in Piedmont (Italy): A Bayesian spatial analysis of the incident cases    Migliaretti G    Amyotrophic Lateral Sclerosis and Frontot.    14(1)            2013    58-65    10.3109/21678421.2012.733401
239    Analytical sequence to study G-CSF effect on the transcriptome of isolated spinal motoneurons from SOD1 G93A mice, an animal model for amyotrophic lateral sclerosis.    Henriques A    Genom Data    4    Elsevier    the Netherlands    2015    47-9    10.1016/j.gdata.2015.02.003
240    Insights Arising from Gene Expression Profiling in Amyotrophic Lateral Sclerosis    Cooper-Knock J    Amyotrophic Lateral Sclerosis, ed. MH Maurer    Chapter 2    InTech    Croatia    2012    41-58    book
241    Metabolomic Analysis Reveals Increased Aerobic Glycolysis and Amino Acid Deficit in a Cellular Model of Amyotrophic Lateral Sclerosi    Valbuena GN    Molecular neurobiology    Humana Press    US    2015        ahead of print
242    The role of oligodendroglial dysfunction in amyotrophic lateral sclerosis    Nonneman A    Neurodegenerative disease management    4    London : Future Medicine    England    2014    223-239    10.2217/nmt.14.21
243    Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset    Tremolizzo L.    Amyotroph Lateral Scler Frontotemporal Degener    15(1-2)            2014    98-105    10.3109/21678421.2013.851247;
244    ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion    Chiò A    Neurobiol Aging                2015    S0197-4580(15)00600-4    10.1016/j.neurobiolaging.2015.11.027